Literature DB >> 26116182

Factor XIII deficiency and head trauma: management and therapy.

Giuseppe Ribizzi1, Daniele Farinini2, Riccarda Gentile2, Domenica Rizzi2, Carlo Serrati2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26116182     DOI: 10.1007/s10072-015-2284-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.

Authors:  Diane Nugent
Journal:  Thromb Res       Date:  2012-12       Impact factor: 3.944

Review 2.  Factor XIII deficiency.

Authors:  L Hsieh; D Nugent
Journal:  Haemophilia       Date:  2008-11       Impact factor: 4.287

3.  Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.

Authors:  Amy E Lovejoy; Tom C Reynolds; Jennifer E Visich; Michael D Butine; Guy Young; Melissa A Belvedere; Rachelle C Blain; Susan M Pederson; Laura M Ishak; Diane J Nugent
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

4.  New developments in the management of congenital Factor XIII deficiency.

Authors:  Zehra Fadoo; Quratulain Merchant; Karim Abdur Rehman
Journal:  J Blood Med       Date:  2013-05-28

Review 5.  Current understanding in diagnosis and management of factor XIII deficiency.

Authors:  M Naderi; A Dorgalaleh; Sh Tabibian; Sh Alizadeh; P Eshghi; Gh Solaimani
Journal:  Iran J Ped Hematol Oncol       Date:  2013-10-22
  5 in total
  1 in total

1.  A journey upstream: Fluctuating platelet-specific genes in cell-free plasma as proof-of-concept for using ribonucleic acid sequencing to improve understanding of postinjury platelet biology.

Authors:  Lucy Zumwinkle Kornblith; Cedric M V Bainton; Alexander T Fields; Zachary A Matthay; Nina T Magid; Brenda Nunez-Garcia; Arun Prakash; Philip A Kurien; Rachael A Callcut; Mitchell J Cohen; Roland J Bainton
Journal:  J Trauma Acute Care Surg       Date:  2020-06       Impact factor: 3.697

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.